2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer

Drug combination therapy is a key strategy to improve treatment efficacy and survival of cancer patients. In this study the effects of combining 2-methoxyoestradiol-3,17-O,O-bis-sulphamate (STX140), a microtubule disruptor, with 2-deoxy-D-glucose (2DG) were assessed in MCF-7 (breast) and LNCaP (pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Tagg, S L C, Foster, P A, Leese, M P, Potter, B V L, Reed, M J, Purohit, A, Newman, S P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600694/
https://www.ncbi.nlm.nih.gov/pubmed/18985042
http://dx.doi.org/10.1038/sj.bjc.6604752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600694/
https://www.ncbi.nlm.nih.gov/pubmed/18985042
http://dx.doi.org/10.1038/sj.bjc.6604752

Ejemplares similares